Brucellosis is a worldwide extended zoonosis caused by Brucella spp. These gram-negative bacteria are not readily detected by innate immunity, a virulence-related property largely linked to their surface lipopolysaccharide (LPS). The role of the LPS lipid A and O-polysaccharide in virulence is well known. Moreover, mutation of the glycosyltransferase gene wadC of B. abortus, although not affecting O-polysaccharide assembly onto the lipid-A core section causes a core oligosaccharide defect that increases recognition by innate immunity. Here, we report on a second gene (wadB) encoding a LPS core glycosyltransferase not involved in the assembly of the O-polysaccharide-linked core section. As compared to wild-type B. abortus, a wadB mutant was sensitive to bactericidal peptides and non-immune serum, and was attenuated in mice and dendritic cells. These observations show that as WadC, WadB is also involved in the assembly of a branch of Brucella LPS core and support the concept that this LPS section is a virulence-related structure.
Introduction
The -2 Proteobacteria of the genus Brucella cause brucellosis, a disease that is considered one of the most common global zoonoses [1] . The genus includes several closely related species among which B. abortus preferentially infects cattle, B. suis swine and wildlife and B. melitensis goats and sheep, and in all these animals brucellosis is a major cause of abortions and infertility. Humans become infected via direct contact with affected livestock and through consumption of unpasteurized dairy products. Human brucellosis is a grave and debilitating disease that may lead to permanent sequelae, requires prolonged and combined antibiotherapy and is fatal in 1-5% of untreated cases [2] .
The brucellae behave as facultative intracellular parasites, and their virulence results from a complex and not fully elucidated set of mechanisms that include the ability to escape prompt detection by innate immunity during the initial stages of infection [3] . Studies carried out mostly with B. abortus have shown that the outer membrane lipopolysaccharide (LPS) [1, 3] lipoproteins [3] and ornithine lipids [4] induce a low proinflammatory response indicative of the absence of the marked pathogen-associated molecular patterns that are detected by innate immunity. These outer membrane components structurally depart from counterparts molecules in most gram-negative bacteria, and the differences are particularly accentuated in the LPS. In B. abortus, B. melitensis and B. suis, LPS is of the smooth (S) type and is thus made of an Opolysaccharide bridged to lipid A by an intermediate core oligosaccharide. Although it has been known for decades that Brucella lipid A and Opolysaccharide are involved in virulence [5] , the role of the core oligosaccharide has only been uncovered recently. We identified a core glycosyltransferase gene (wadC) whose disruption increases recognition of the LPS by complement, bactericidal peptides and the receptor complex MD2-TLR4, which leads to an increase in the proinflammatory response and the subsequent attenuation of the mutated bacteria [6] . Mutants in wadC remain S (i.e. they carry the O-polysaccharide), which is in contrast with the lack of a S-LPS of mutants in wadA, the only other glycosyltransferase known to be involved in the synthesis of the Brucella LPS core [7] . On these bases, we proposed that the B. abortus LPS core has a branched structure [6] and this was confirmed in a more recent structural study [8] . Here, we report that wadB, a hitherto unidentified LPS gene, encodes a glycosyltransferase involved in the synthesis of the LPS core branch, and show that its disruption also leads to attenuation.
Experimental procedures

Bacterial strains and growth conditions.
The bacterial strains and plasmids used in this study are listed in Table 1 . Bacteria were routinely grown in standard tryptic soy broth (TSB; Biomerieux; http://www.biomerieux.com) or agar (TSA; Conda-Pronadisa; http://www.condalab.com/es) either plain or supplemented with kanamycin (Km) at 50 μg/mL, chloramphenicol (Cm) at 20 μg/mL, nalidixic acid (Nal) at 25 μ g/mL, and/or 5% sucrose. All strains were stored in skim milk (Scharlau) at -80°C .
DNA manipulations.
Plasmid and chromosomal DNA were extracted with Qiaprep spin Miniprep (Qiagen GmbH, Hilden, Germany) and Ultraclean Microbial DNA Isolation Kit (Mo Bio Laboratories) respectively. When needed, DNA was purified from agarose gels using a Qiaquick Gel extraction kit (Qiagen). DNA sequencing was performed by "Servicio de Secuenciación del CIMA" ("Centro de Investigación Médica Aplicada", Pamplona, Spain). Primers were synthesized by Sigma-Genosys Ltd. (Haverhill, United Kingdom). Searches for DNA and protein homologies were carried out using the NCBI (National Center for Biotechnology Information; http://www. ncbi.nlm.nih.gov) and the KEGG database (http://www.genome.jp/kegg/) servers. Analysis of glycosyltransferases families and domains was performed using CAZy database (www.cazy.org).
An in-frame deletion mutant in BAB1_0351 (henceforth BaΔwadB) was constructed by PCR overlap using genomic DNA of B. abortus 2308 (Baparental) as DNA template. Primers were designed based on the sequence of B. abortus 2308 (http://www.ncbi.nlm.nih.gov/). First, two PCR fragments were generated: oligonucleotides wadB-F1 (5´-GCATGATTACCCCGCTGAT-3´) and wadB-R2 (5´-CGCAATCTCGTCTTTGTTGAG-3´) were used to amplify a 296 bp fragment including codons 1 to 48 of BAB1_0351 as well as 152 bp upstream of the BAB1_0351 start codon; and oligonucleotides wadB-F3 (5´-CTCAACAAAGACGAGATTGCGGGTGGCGTGAAGGAAATCT-3´) and wadB-R4 (5´-TGATAGCCGAGCCTCTTCAG-3´) were used to amplify a 274 bp fragment including codons 196 to 239 of the ORF and 139 bp downstream of the stop codon. Both fragments were ligated by overlapping PCR using oligonucleotides wadB-F1 and wadB-R4 for amplification and the complementary regions between wadB-R2 and wadB-F3 for overlapping. The resulting fragment, containing the BAB1_0351 deletion allele, was cloned into pCR2.1 (Invitrogen), to generate plasmid pYRI-1, sequenced to ensure the maintenance of the reading frame, and subsequently subcloned into the BamHI and the XbaI sites of the suicide plasmid pJQKm ( Table 1 ). The resulting mutator plasmid (pYRI-2) was introduced in Ba-parental by conjugation. The first recombination (integration of the suicide vector in the chromosome) was selected by Nal and Km resistance, and the second one (excision of the mutator plasmid producing the mutant by allelic exchange) by Nal and sucrose resistance and Km sensitivity. The resulting colonies were screened by PCR with primers wadB-F1 and wadB-R4, which amplify a fragment of 570 bp in the mutant and a fragment of 1011 bp in Ba-parental. The mutation resulted in the loss of 60% of the ORF (88% of the glycosyltransferase domain).
For complementation, a plasmid harboring ORF BAB1_0351 (pwadB) was constructed as described previously [9] using genomic DNA of B. abortus 2308 as the DNA template. Briefly, PCR-amplified ORF BAB1_0351 was inserted into the Gateway-compatible vector pDONR221 by site-specific recombination (pYRI-3). The product was then introduced into One Shot® OmniMAX™ 2-T1R Chemically Competent E. coli cells and the bacterial transformants were selected on TSA-Km. The clone carrying B. abortus BAB1_0351 was extracted, and the DNA containing this ORF was subcloned in pRH001 [10] to produce plasmid pwadB. To complement the wadB mutation, plasmid pwadB was introduced into BaΔwadB by mating with E. coli S17-1λpir and the conjugates harboring pwadB were selected by plating onto TSA-Nal-Cm plates, which were incubated at 37°C for 3 days.
For detection of bacteria in the cell infection experiments (see below), plasmid pBBR1MCS-2 GFP was introduced by conjugation in the different Brucella strains (Table 1 ).
Sensitivity to brucellaphages, dyes, antibiotics and polymyxin.
The sensitivity to the S (Tb, Wb, Iz) and R (R/C) specific brucellaphages was measured as described previously [11] . The minimal inhibitory concentration (MIC) of fuchsin, thionin and safranin (dyes used in Brucella biovar typing) was determined in Müller-Hinton broth by standard procedures. For polymyxin B, exponentially growing bacteria were adjusted to an optical density equivalent to 1 of the McFarland scale. The MIC was determined by the E-test method (AB Biomérieux, Solna, Sweden) on Müller-Hinton agar.
Sensitivity to non-immune serum.
Exponentially growing bacteria were adjusted to 10 4 colony forming unit (CFU/mL) in phosphate buffered saline (PBS) and dispensed in triplicate in microtiter plates (45 μL/well) containing fresh normal bovine serum (90 μL/well).
After 90 min of incubation at 37 °C, 200 μL of brain heart infusion broth was dispensed into each well, the bacterial suspension mixed, and 100 μL aliquots plated on TSA. The Ba::Tn5-per (R-LPS) and Ba::Tn5-bvrR (S-LPS) mutants were used as controls. The results were expressed as the percentage of survival with respect to the CFU in the inocula.
LPS extraction and characterization.
S-LPS was obtained by methanol precipitation of the phenol phase of a phenol-water extract, followed by digestion with nucleases (10 mg S-LPS/mL in 175 mM NaCl, 0.05% NaN 3 , 0.1M Tris-HCl [pH 7.0]; 50 μg/mL each of DNase-II type V, and RNase [Sigma, St. Louis, Missouri, U.S.A.] 30 min at 37°C) and proteinase K (three cycles; 50 μg/mL, 3 h at 55°C). LPS was then sedimented by ultracentrifugation, extracted four times with chloroform-methanol (2:1 [vol/vol]) to remove free lipids, and freeze-dried [12] . Alternatively, LPS was extracted from whole bacteria by the sodium dodecylsulfate (SDS) -proteinase K protocol [13] . LPS were electrophoresed in 7 cm 18% polyacrylamide (PAGE) gels in SDS Tris-HCl-glycine [1, 14] . Alternatively, LPS were analyzed in 16 cm 18% PAGE gels in Tris-Tricine-HCl-glycine (TSDS-PAGE) [2, 15] . For Western blots, gels were electro transferred onto nitrocellulose sheets (Whatman, Dassel, Germany), blocked with 3% skim milk in PBS with 0.05% Tween 20 (PBST) overnight, and washed with the same buffer. Monoclonal antibodies A68/03F03/D05, A68/24D08/G09 and A68/24G12/A08 (all of which recognize R-LPS epitopes [3, 16] ) were diluted in PBST and blots were developed with peroxidase-conjugated goat anti-mouse immunoglobulin (Nordic immunological laboratories, Tilburg, Netherlands) or peroxidase labeled protein G and 4-chloro-1-naphtol-H 2 O 2 .
Polycationic peptide-LPS interactions.
The affinity of Ba-parental and BaΔwadB LPS for polycationic peptides was measured using peptide 19.8-4 (derived from the Limulus anti-LPS factor) [1, 3, 17] in comparison with the LPS of the B. abortus wadC mutant (BaΔwadC) described previously [3, 6] , and E. coli ATCC 35218. For this purpose, ELISA plates were coated with the peptide (10 µg/mL in 20 mM in PBS; 100 µl/well) at 4ºC overnight and washed extensively with PBS-Tween 20. Then, the appropriate LPS was dispensed (10 µg/mL in PBS; 100 µl/well) and plates incubated at 37ºC for 1 h. Free peptide was detected with biotinylated E. coli LPS (100 µl/well of 1 µg/mL in PBS for 30 min at 37 ºC) and a horseradish peroxidase-conjugated Streptavidin (100 μL; 1/2000 in PBS at room temperature for 30 min) -2,2'-azino-bis(3-ethylbenzthiazoline-6-sulphonic acid)/H 2 O 2 system. Binding was expressed as the ratio [(LPS tested -LPS 0 ) x 100]/ (LPS Ec -LPS 0 ) where LPS tested is the value obtained with the LPS of each B. abortus strain, LPS Ec is the value obtained with E. coli LPS, and LPS 0 the values obtained for the biotinylated E. coli LPS and no buffer and no LPS in the binding steps.
Intracellular replication.
Bone marrow cells were isolated from femurs of 7-8-week-old C57BL/6 female mice and differentiated into bone marrow-derived dendritic cells (BMDCs) as described previously [4, 9, 18, 19] . Infections were performed by centrifuging bacteria carrying the plasmid pBBR1-MCS-2 GFP onto BMDCs (400 x g for 10 min at 4ºC; multiplicity of infection of 40) followed by incubation at 37°C for 30 min under a 5% CO 2 atmosphere. The virB10 GFP mutant was used as an avirulent control. BMDCs were washed extensively to remove extracellular bacteria and incubated in complete medium supplemented with 50 g/mL gentamicin for 1 h to kill extracellular bacteria. Thereafter, the antibiotic concentration was decreased to 10 g/mL.
To determine the number of intracellular bacteria per cell, BMDCs were grown on glass coverslips and inoculated with bacteria as described above. At 2 and 48 h post-inoculation, coverslips were fixed with 3% paraformaldehyde, pH 7.4, at 37°C for 15 min and washed three times with PBS. Coverslips were processed for immunofluorescence staining as previously described [5, 20] . BMDCs were labeled using an antibody (rabbit anti mouse Rivoli) against a conserved cytoplasmic domain of MHC-II I-A-β subunits [6, 21] , followed by the secondary antibody donkey anti-rabbit Cy5. Bacteria were visualized directly since they expressed the green fluorescence protein encoded by the pBBR1MCS-2 GFP plasmid. For each bacterial infection, a minimum of one hundred cells was analyzed under a Zeiss Axioplan 2 Fluorescence Microscope. The number of cells containing more than 10 bacteria/cell was recorded and expressed as a percentage with respect to the number of total infected cells. These experiments were done at least three times.
Virulence assay in mice.
One week before the start of the experiment, 7 week-old female BALB/c mice (Charles River, Elbeuf, France) were accommodated in cages with water and food ad libitum under biosafety containment conditions in the animal BaΔwadB, BaΔwadC or Ba-parental, and the number of CFU in spleens was determined at 2, 4, 8, 12 and 24 weeks post-inoculation, as described previously [6, 7] . An additional group of 10 mice were infected with the BaΔ wadB-pwadB complemented strain, and analyzed at 8 and 12 weeks postinfection. The identity of the spleen isolates was confirmed by PCR at each point-time and the individual data (CFU/spleen) were normalized by logarithmic transformation and expressed as the mean and standard deviation (n=5) of log 10 CFU/spleen. Statistical comparisons of means were performed by a oneway ANOVA test followed by the Fisher's Protected Least Significant Differences (PLSD) test.
Results
Identification of wadB, a glycosyltransferase gene involved in the synthesis of the LPS core section not linked to the O-polysaccharide.
To identify Brucella core glycosyltransferase candidates, we first searched the KEGG database (http://www.genome.jp/kegg/) for glycosyltransferases in Brucella spp., ruling out those previously assigned to the O-polysaccharide. Then, we looked for orthologous of these ORFs in Ochrobactrum anthropi (ATCC 49188), a close phylogenetic relative of Brucella that has a core structure close to that of B. abortus [6, 8, 22] . In addition to the Kdo transferase (BAB2_0209, kdtA or waaA), which is highly conserved in gram-negative bacteria and thus of less interest, we found B. abortus BAB1_1522 and O. anthropi Oant_1661 to be the closest (85.6%) homologues, followed by BAB1_0351 and Oant_0415 (62.0% homology) and BAB1_0639 and Oant_0608 (38.9%). Other matches showed less than 35% homology, the threshold below which protein sequence alignment becomes meaningless [8, 23] . Of these three ORFs, B. abortus BAB1_1522 encodes WadC and B. abortus BAB1_0639 encodes WadA, the only two core glycosyltransferases described previously [7, 9, 24] . Their identification supported the appropriateness of the screening method and, accordingly, the remaining ORF (BAB1_0351) was a strong candidate for an additional core glycosyltransferase. Consistent with this possibility, the BAB1_0351 predicted protein contained the cI01298, cd06532 and PFAM01755 domains of glycosyltransferase family 25, which includes Brucella WadA as well as LPS glycosyltransferases of other bacteria. Following the accepted nomenclature for LPS genes [10, 25] , we provisionally named this gene wadB.
To investigate whether BAB1_0351 was in fact involved in LPS synthesis, we constructed a non-polar mutant by in frame deletion of the sequence coding for amino acids 49 to 195, which eliminated the three consensus domains of glycosyltransferase family 25. The non-polar mutant (BaΔwadB) did not differ from the parental strain (Ba-parental) in growth rate, sensitivity to fuchsin, thionin and safranin. Moreover, the parental and the mutant strains showed similar sensitivity and resistance, respectively, to S and R brucellaphages [11] , and an anti-S-LPS serum agglutinated both strains similarly. We then extracted the LPS from BaΔwadB, the pwadB-complemented and the parental strain, and compared the profiles in standard Tris-glycine SDS-PAGE ( Figure 1A ). The analysis showed that the high molecular weight S-LPS fraction of both BaΔ wadB and Ba-parental had a similar profile. On the other hand, the R (low molecular weight) LPS fraction showed an increased mobility suggestive of a core defect ( Figure 1A ), and complementation with plasmid pwadB restored the parental mobility profile ( Figure 1A ). When we probed the BaΔwadB LPS with antibodies specific for the core of Brucella LPS, Moab A68/24G12/A08 ( Figure  1B ), A68/24D08/G09 and A68/3F03/D05 (not shown) failed to react with either the high (S) or low molecular weight (R) fractions of the LPS of BaΔwadB, and complementation with plasmid pwadB restored the reactivity. We finally compared the LPS of BaΔwadB and BaΔwadC by Tris-tricine-HCl-glycine SDS-PAGE, a high-resolution method that showed a higher molecular weight for R-LPS fraction of the former ( Figure 1C) . Since these results demonstrate that it encodes a core glycosyltransferase, they confirm the appropriateness of the wadB designation. Moreover, they show that WadB is not related to the section linked to the O-polysaccharide, and suggest that the LPS core defect in BaΔ wadB is less severe than that in BaΔwadC.
Deletion of wadB decreases the resistance to the bactericidal action of polycationic peptides and normal serum.
B. abortus is characteristically resistant to killing by non immune serum and polycationic bactericidal peptides, two properties linked to the LPS structure. Thus, we first probed the mutants with polymyxin B. The MICs we found were 1.5 µg/mL for Ba-parental, 0.75 µg/mL for BaΔwadC, 0.30 µg/mL for BaΔwadB and 1.5 µg/mL for the pwadB-complemented Ba∆wadB strain. To confirm that the defective core LPS is responsible for the increased sensitivity of the wadB mutant to polycationic peptides, we also probed the binding of purified LPS to the potent Limulus anti-LPS peptide 19.8-4 [12, 17] . We found that the LPS of BaΔwadB and BaΔwadC bound more peptide than the LPS of Ba-parental (Figure 2, left panel) . Binding of peptide 19.8-4 was much less intense for any B. abortus LPS than for E. coli LPS indicating than the core accounts only in part for the LPS-mediated resistance of B. abortus to polycationic peptides. This is in accordance with previous works that showed that, in contrast to enterobacterial lipid A, polymyxin B failed to bind B. abortus lipid A [13, 26] .
Concerning the resistance to the killing action of normal serum, we observed that BaΔwadB and BaΔwadC were more sensitive than Ba-parental and that the core defect was less deleterious than the upset OM present in a mutant in the master regulator BvrR-S [27, 28] (Figure 2, right panel) .
Interestingly, BaΔwadB, BaΔwadC and a Ba::Tn5-per mutant lacking the Opolysaccharide but carrying an intact core (see Table 1 for reference) showed similar serum sensitivity (Figure 2, right panel) . These results demonstrate that an intact core is as important as the O-polysaccharide in protecting S B. abortus against killing by bactericidal systems in normal serum.
Deletion of wadB causes attenuation in dendritic cells and mice.
B. abortus is characteristically able to multiply in dendritic cells [29] . To study the behavior of BaΔwadB in these cells, we infected C57BL/6 BMDC with BaΔwadB, BaΔwadC and Ba-parental, and scored the number of intracellular bacteria in infected MHCII positive cells at 2 and 48 h post-infection. As a control, we used a virB10 mutant (Table 1 ) defective in the Type IV secretion system required for normal intracellular trafficking and multiplication. As expected [20, 29] , and regardless of the strain, the vast majority of infected BMDCs contained less than 10 bacteria at 2 h post-infection ( Figure 3A) . At 48 h post-infection, the proportion of BMDCs containing more than 10 bacteria increased for Ba-parental but not for the virB10 GFP mutant, as expected from their respective virulent and attenuated phenotype [6] . Both BaΔwadC and BaΔ wadB displayed an intermediate phenotype ( Figure 3A) , as described before for the former mutant [6] .
We finally tested BaΔwadB in mice in comparison with BaΔwadC and Baparental. Both BaΔwadB and BaΔwadC were attenuated ( Figure 3B ). Although the differences were not marked, the evolution of the CFU/spleen suggested a less attenuated profile for BaΔwadB, with higher CFU/spleen at weeks 8 and 24 (p<0,05) ( Figure 3B ). In an independent experiment, the CFU/spleen obtained for the BaΔwadB -pwadB complemented control were similar to those of Baparental strains at the post-infection time tested (8 weeks; mean and standard deviation of log CFU 6.14 ±0.39 and 6.63±0.50 respectively; p = 0.442).
Discussion
The results of this work extend those of a previous study in which we showed that a B. abortus mutant in wadC displayed an altered LPS core despite carrying the O-polysaccharide [6] . Kubler-Kielb and Vinogradov [8] have shown that, whereas the B. abortus, B. melitensis and B. suis N-formyl-perosamine Opolysaccharide is linked to a few sugars stemming from the distal 3-deoxy-Dmanno-octulosonic-acid residue (Kdo2) of the core, the lipid A-linked Kdo1 is bound through mannose to four glucosamine units. Fully consistent with the identification of wadB and the characteristics of the BaΔwadB mutant, synthesis of this oligosaccharide should require more than one glycosyltransferase. Based on the arrangement of sugars in this oligosaccharide, the electrophoretic profiles reported here, and the annotation of wadC as a mannosyltransferase gene, it can be hypothesized that WadC transfers mannose to Kdo1 and that WadB takes part in a later step. Indeed, although the genomic comparisons do not clarify its substrate specificity, it can also be hypothesized that WadB acts as a glucosamine transferase (Figure 4) . Consistent with the description of the core branch in the above-mentioned S Brucella species [8] , orthologues of wadB and wadC are present in all these bacteria and their disruption does not alter their S phenotype (Mancilla, M., Conde-Álvarez, R., Moriyón, I, and M. Iriarte; unpublished results).
Based on the observation that the core defect in BaΔwadC generates attenuation and that the mutated LPS is more readily recognized by elements of innate immunity, we have proposed that the Brucella LPS core branch is a virulence-related structure accounting in part for the stealthy behavior of these bacteria [3, 6] . Since mutation of another glycosyltransferase involved in the synthesis of the same structure also causes attenuation, our hypothesis is confirmed in the present work. As reported before (and confirmed here) for wadC, the disruption of the core caused by mutation of wadB diminished the resistance to bactericidal peptides and non-immune serum, increased peptide binding to LPS, and generated strains that were attenuated in dendritic cells and mice. It has to be noted that, although showing an overall similarity, the phenotypes of the BaΔwadB and BaΔwadC mutants were not identical. In vitro, we noted differences in polymyxin B sensitivity, a polycationic lipopeptide that targets the lipid A phosphates and anionic sugars in the inner core (the Kdo residues in the case of Brucella). Indeed, disruption of the Kdo1 glucosamine branch easily explains the decreased resistance of both mutants. However, the decrease did not parallel the extent of core damage observed in the electropherograms, and thus other factors may be relevant. They could relate to topological changes in other outer membrane components, to the three dimensional arrangement of the remaining core, or to both. On the other hand, the experiments in mice suggested a less attenuated phenotype for wadB than for wadC that would be consistent with a less severe damage of the LPS core. A putative model of LPS structure based on the studies of Kubler-Kielb and Vinogradov (8) and our results studying the role of wadC and wadB is presented in Figure 4 . Obviously, a definite interpretation of these results requires structural elucidation of the core structure remaining in the wadB and wadC mutants or/ and in a wadB-wadC double mutant.
We have proposed before that disruption of the structure of the Brucella LPS core can be exploited to develop vaccines that would elicit the early innate immunity recognition that leads to Th1 protective responses [24] . Although vaccine S19 has been successfully used in developed countries for the control and eradication of cattle brucellosis, the protection achieved is not optimal [30] and success using this vaccine requires a very proficient veterinary infrastructure. Previous experiments in the mouse model suggest that the B. abortus wadC core mutations could be either introduced in S19 to reduce its residual virulence but bolstering its immunogenic properties or in a wild-type background, in combination with other appropriate mutations, to develop improved vaccines [24] . In this context, the identification of wadB adds another target for the development of new generation anti-Brucella vaccines less pathogenic and more immunogenic than currently available vaccines A study of the vaccine properties of wadB and wadC mutants in various Brucella backgrounds is in progress. 
